Inhaler Carbon Impact Assessment Tool

26th Mar 2021

The Prescribing Support Team at the RDTC have been developing an Inhaler Carbon Impact Assessment Tool, which aims to provide the carbon impact alongside the financial impact of potential formulary inhaler choices. Stage 2 of this tool, which considers SABA, SAMA & LAMA, LABA and ICS inhalers, is now available on the Respiratory reports page of the RDTC website. (Please contact RDTC to request log in details.)